Which patients should be operated on after induction chemotherapy for N2 non-small cell lung cancer? Analysis of a 7-year experience in 175 patients

Journal of Thoracic and Cardiovascular Surgery

Volumn 140, Issue 2, 2010, Pages 356-363

  Stefani, Alessandro ^a   Alifano, Marco ^a   Bobbio, Antonio ^a   Grigoroiu, Madalina ^a   Jouni, Rami ^a   Magdeleinat, Pierre ^a   Regnard, Jean Francois ^a  

^a HÔTEL DIEU   (France)

Author keywords

computed tomography; CT; EORTC; European Organisation for Research and Treatment of Cancer; median survival time; MST; non small cell lung cancer; NSCLC; PET; PFS; positron emission tomography; progression free survival

Indexed keywords

ANTINEOPLASTIC AGENT; GEMCITABINE; NAVELBINE; PACLITAXEL;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL TIME; TREATMENT RESPONSE;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CHEMOTHERAPY, ADJUVANT; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; PATIENT SELECTION; PNEUMONECTOMY; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 77955469830     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2010.02.018     Document Type: Article

References (25)

1. N. Martini, M.G. Kris, B.J. Flehinger, R.J. Gralla, M.S. Bains, and M.E. Burt et al. Preoperative chemotherapy for stage IIIA (N2) lung cancer: the Sloan-Kettering experience with 136 patients Ann Thorac Surg 55 1993 1365 1374
2. F. Andre, D. Grunenwald, J. Pignon, A. Dujon, L. Pujol, and P. Brichon et al. Survival of patients with resected N2 non-small-cell lung cancer: evidence for a subclassification and implications J Clin Oncol 18 2000 2981 2989
3. K.S. Albain, V.W. Rusch, J.J. Crowley, T.W. Rice, A.T. Turrisi, and J.K. Weick et al. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stage IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II Study 8805 J Clin Oncol 13 1995 1880 1892
4. W. Eberhardt, H. Wilke, G. Stamatis, M. Stuschke, A. Harstrick, and H. Menker et al. Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small-cell lung cancer: mature results of a phase II trial J Clin Oncol 16 1998 622 634
5. N. Lorent, P. DeLeyn, Y. Lievens, E. Verbeken, K. Nackaerts, and C. Dooms et al. Long-term survival of surgically staged IIIA-N2 non-small-cell lung cancer treated with surgical combined modality approach: analysis of a 7-year prospective experience Ann Oncol 15 2004 1645 1653
6. H.I. Pass, H.V. Pogrebniak, S.M. Steinberg, J. Mulshine, and J. Minna Randomized trial of neoadjuvant therapy for lung cancer: interim analysis Ann Thorac Surg 53 1992 992 998
7. R. Rosell, J. Gómez-Codina, C. Camps, J. Maestre, J. Padille, and A. Cantó et al. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer N Engl J Med 330 1994 153 158
8. J.A. Roth, F. Fossella, R. Komaki, M.B. Ryan, J.B. Putnam, and J.S. Lee et al. A randomized trail comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer J Natl Cancer Inst 86 1994 673 680
9. C. Doddoli, F. Barlesi, D. Trousse, S. Robitail, S. Yena, and P. Astoul et al. One-hundred consecutive pneumonectomies after induction therapy for non-small cell lung cancer: an uncertain balance between risks and benefits J Thorac Cardiovasc Surg 130 2005 416 425
10. P. Garrido, J.L. Gonzalez-Larriba, A. Insa, M. Provencio, A. Torres, and D. Isla et al. Long-term survival associated with complete resection after induction chemotherapy in stage IIIA (N2) and IIIB (T4N0-1) non-small-cell lung cancer patients: the Spanish Lung Cancer Group Trial 9901 J Clin Oncol 25 2007 4736 4742
11. M. Alifano, M.S. Boudaya, M. Salvi, J.Y. Collet, C. Dinu, and S. Camilleri-Broet et al. Pneumonectomy after chemotherapy: morbidity, mortality and long-term outcome Ann Thorac Surg 85 2008 1866 1873
12. K.S. Albain, R.S. Swann, V.R. Rusch, A.T. Turrisi, F.A. Shepherd, and C.J. Smith et al. Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial Lancet 374 2009 379 386
13. J.P. Van Meerbeeck, G.W.P.M. Kramer, P.E.Y. Van Schil, C. Legrand, E.F. Smit, and F. Schramel et al. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer J Natl Cancer Inst 99 2007 442 450
14. L.A. Robinson, J.C. Ruckdeschel, H. Wagner Jr., and C.W. Stevens Treatment of non-small cell lung cancer - stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition) Chest 132 3 Suppl 2007 243S 265S
15. Standards, options: recommandations. Traitement péri- opératoire des patients atteints d'un cancer bronchique non à petites cellules résécable d'emblée, opérables (rapport intégral). Rapport original 2000, mise à jour 2007. Available at: http://www.sor-cancer.fr
16. A.B. Miller, B. Hoogstraten, M. Staquet, and A. Winkler Reporting results of cancer treatment Cancer 42 1981 207 214
17. A. Depierre, B. Milleron, D. Moro-Sibinot, S. Chevret, and E. Quoix et al. Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II and IIIA non-small cell lung cancer J Clin Oncol 20 2001 247 253
18. K. Nagai, R. Tsuchiya, T. Mori, H. Tada, Y. Ichinose, and T. Koike et al. A randomized trial comparing induction chemotherapy followed by surgery with surgery alone for patients with stage IIIA N2 non-small cell lung cancer (JCOG 9209) J Thorac Cardiovasc Surg 125 2003 254 260
19. W.E. Eberhardt, K.S. Albain, H. Pass, J.B. Putnam, A. Gregor, and H. Assamura Induction treatment before surgery for non-small-cell lung cancer: IASLC consensus report Lung Cancer 42 2003 S9 S14
20. D.C. Betticher, S.F. Hsu Schmitz, M. Tötsch, E. Hansen, C. Joss, and C. von Briel et al. Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer: a multicenter phase II trial J Clin Oncol 21 2003 1752 1759
21. J.L. Port, R.J. Korst, P.C. Lee, M.A. Levin, D.E. Becker, and R. Keresztes et al. Surgical resection for residual N2 disease after induction chemotherapy Ann Thorac Surg 79 2005 1686 1690
22. R. Bueno, W.G. Richards, S.J. Swanson, M.T. Jaklitsch, J.M. Lukanich, and S.J. Mentzen et al. Nodal stage after induction therapy for stage IIIA lung cancer determines patient survival Ann Thorac Surg 70 2000 1826 1831
23. M. De Waele, M. Serra-Mitjans, J. Hendriks, P. Lauwers, J. Belda-Sanchis, and P. Van Schil et al. Accuracy and survival of repeat mediastinoscopy after induction therapy for non-small-cell lung cancer in a combined series of 104 patients Eur J Cardiothorac Surg 33 2008 824 828
24. A. Szlubowski, J. Kuzdal, M. Kolodziej, J. Soja, J. Pankowski, and A. Obrochta et al. Endobronchial ultrasound-guided needle aspiration in the non-small cell lung cancer staging Eur J Cardiothorac Surg 35 2009 332 336
25. K. Adams, P.L. Shah, L. Edmonds, and E. Lim Test performance of endobronchial ultrasound and transbronchial needle aspiration biopsy for mediastinal staging in patients with lung cancer: systematic review and meta-analysis Thorax 64 2009 757 762